The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | EUREKA: establishing a sample sharing network to improve diagnosis & management of AL amyloidosis
Mario Nuvolone, MD, PhD, University of Pavia, Pavia, Italy, shares insights into the EUREKA study (NCT06205953), which aims to promote the diagnosis and management of light chain (AL) amyloidosis. This involves the establishment of a large prospective registry of all new cases of AL amyloidosis at four European referral centers and their satellite sites, as well as the creation of a network of shared biorepositories to allow for studying mechanisms of the disease through the use of advanced molecular technologies and big data analysis tools. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
